UNSPSC 51263141: Esatenolol or s-atenolol

This classification denotes a beta-adrenergic blocking agent with the molecular formula C14H22N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DPF757BOSR, chemically known as 2-[4-[(2S)-2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide but generally known as s-atenolol or esatenolol, which bears US NIH Compound Identifier 175540. European Medicines Agency schedules s-atenolol or esatenolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06608MIG.

UNSPSC 51263141 Esatenolol or s-atenolol is a Commodity code that shows minimal recent activity aligned with its pharmaceutical scope. The single recent state and local opportunity tagged to this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems, which fall outside the beta-blocker pharmaceutical class the code nominally covers. The mismatch suggests either a tagging error by the issuing body or that this code does not currently reflect active state and local procurement for esatenolol or related atenolol formulations.

No recent opportunities support active procurement of esatenolol or s-atenolol itself under this code. Business development professionals evaluating this Commodity should consider whether the single visible opportunity represents genuine misclassification or a signal that state and local governments are not currently issuing solicitations for this specific pharmaceutical. Verify directly with issuing bodies—particularly state health departments, correctional agencies, and county health systems that typically procure maintenance cardiovascular medications—whether procurement activity exists but remains untagged to this code, or whether demand has shifted to alternate sourcing channels such as cooperative purchasing agreements or prime vendor contracts managed at the state level.